https://orcid.org/0000-0003-3085-6275
References
- Ruiz-Aragón J, Gani R, Márquez S, Alvarez P. Estimated cost-effectiveness and burden of disease associated with quadrivalent cell-based and egg-based influenza vaccines in Spain. Hum Vaccin Immunother. published online February 10, 2020;2020:1–7. doi:10.1080/21645515.2020.1712935.
- Word Health Organization. WHO guide for standardization of economic evaluations of immunization programmes. 2nd ed. Geneva (Switzerland): World Health Organization; 2019. Available at https://www.who.int/immunization/documents/who_ivb_19.10/en/
- Mauskopf J, Standaert B, Connolly MP, Culyer AJ, Garrison LP, Hutubessy R, Jit M, Pitman R, Revill P, Severens JL. Economic Analysis of Vaccination Programs: An ISPOR Good Practices for Outcomes Research Task Force Report. Value in Health. 2018;21:1133–49. doi:10.1016/j.jval.2018.08.005
- Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. BMC Medicine 2013;11:80. doi:10.1186/1741-7015-11-80
- Boikos C, Sylvester GC, Sampalis JS, Mansi JA. Relative effectiveness of the cell-cultured quadrivalent influenza vaccine compared to standard, egg-derived quadrivalent influenza vaccines in preventing influenza-like illness in 2017–2018. Clin Infect Dis. 2020; published online April 7, 2020. doi:10.1093/cid/ciaa371
- DeMarcus L, Shoubaki L and Federinko S. Comparing influenza vaccine effectiveness between cell-derived and egg-derived vaccines, 2017-2018 influenza season. Vaccine. 2019;37:4015–21.
- Izurieta HS, Chillarige Y, Kelman J, Wei Y, Lu Y, Xu W, Lu M, Pratt D, Chu S, Wernecke M, MaCurdy T, Forshee R. Relative Effectiveness of Cell-Cultured and Egg-Based Influenza Vaccines Among Elderly Persons in the United States, 2017–2018. J Infect Dis. 2019; 220:1255–64. doi:10.1093/infdis/jiy716
- Izurieta HS, Chillarige Y, Kelman J, Wei Y, Lu Y, Xu W, Lu M, Pratt D, Wernecke M, MaCurdy T, Forshee R. Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018–2019. J of Infect Dis. 2020;222:278–87. doi:10.1093/infdis/jiaa080
- Klein NP, Fireman B, Goddard K, Zerbo O, Asher J, Zhou J, King J, Lewis N. Vaccine effectiveness of flucelvax relative to inactivated influenza vaccine during the 2017-18 influenza season in Northern California. Presented at: lnfectious Disease (ID) Week Congress; 2020 Oct 6. San Francisco (CA). Available at https://idsa.confex.com/idsa/2018/webprogram/Paper74111.html
- Bruxvoort KJ, Luo Y, Ackerson B, Tanenbaum HC, Sy LS, Gandhi A, Tseng HF. Comparison of vaccine effectiveness against influenza hospitalization of cell-based and egg-based influenza vaccines, 2017–2018. Vaccine. 2019;37(39):5807–11. doi:10.1016/j.vaccine.2019.08.024.